AMGEN INC: Pursues Stay of Human Genome Suit for Appeals Review
October 19, 2009
Human Genome Sciences and Amgen Inc. seek to stay an action to review a decision on priority and judgment by the Board of Patent Appeals and Interference in the U.S.…